- Home
- RGCO vs NVCT Comparison
RGCO vs NVCT Comparison
Compare RGCO & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGCO | NVCT |
|---|---|---|
| Founded | 1912 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.9M | 220.0M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGCO | NVCT |
|---|---|---|
| Price | $22.74 | $9.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 8.2K | ★ 48.5K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 11.21 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $95,334,212.00 | N/A |
| Revenue This Year | $8.27 | N/A |
| Revenue Next Year | $3.36 | N/A |
| P/E Ratio | $47.96 | ★ N/A |
| Revenue Growth | ★ 12.63 | N/A |
| 52 Week Low | $19.68 | $5.55 |
| 52 Week High | $23.82 | $11.52 |
Technical Indicators
Market Signals| Indicator | RGCO | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 62.21 | 58.06 |
| Support Level | $20.49 | $8.01 |
| Resistance Level | $23.01 | $9.20 |
| Average True Range (ATR) | 0.57 | 0.38 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 92.89 | 79.17 |
Price Performance
Historical ComparisonAbout RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.